Insider Transactions in Q1 2023 at First Northwest Bancorp (FNWB)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 17
2023
|
Matthew Deines President / CEO |
BUY
Open market or private purchase
|
Direct |
6,000
+3.38%
|
$66,000
$11.15 P/Share
|
Mar 15
2023
|
Dana D. Behar Director |
BUY
Open market or private purchase
|
Direct |
900
+2.58%
|
$10,800
$12.02 P/Share
|
Mar 13
2023
|
Dana D. Behar Director |
BUY
Open market or private purchase
|
Direct |
3,000
+4.24%
|
$33,000
$11.96 P/Share
|
Mar 13
2023
|
Norman J. Tonina Jr. Director |
BUY
Open market or private purchase
|
Direct |
2,100
+5.65%
|
$25,200
$12.19 P/Share
|
Mar 08
2023
|
Dana D. Behar Director |
BUY
Open market or private purchase
|
Direct |
1,000
+3.22%
|
$13,000
$13.88 P/Share
|
Mar 07
2023
|
Sherilyn G Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,101
+14.38%
|
$46,515
$15.03 P/Share
|
Mar 07
2023
|
Terry A Anderson EVP, Chief Credit Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,342
-3.53%
|
$18,788
$14.8 P/Share
|
Mar 07
2023
|
Christopher J Riffle EVP, COO and CDO |
SELL
Payment of exercise price or tax liability
|
Direct |
807
-2.51%
|
$10,491
$13.9 P/Share
|
Mar 07
2023
|
Geraldine L. Bullard EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
963
-4.19%
|
$12,519
$13.9 P/Share
|
Mar 07
2023
|
Derek J Brown EVP, Chief HR/Marketing Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
559
-2.41%
|
$7,267
$13.9 P/Share
|
Mar 07
2023
|
Matthew Deines President / CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,547
-1.91%
|
$20,111
$13.9 P/Share
|
Mar 07
2023
|
Jennifer Zaccardo Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+4.27%
|
$22,750
$14.31 P/Share
|
Mar 07
2023
|
Norman J. Tonina Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+4.43%
|
$22,750
$14.31 P/Share
|
Mar 07
2023
|
Stephen E. Oliver Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+5.55%
|
$22,750
$14.31 P/Share
|
Mar 07
2023
|
Gabriel Steven Galanda Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+23.34%
|
$22,750
$14.31 P/Share
|
Mar 07
2023
|
Cindy H. Finnie Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+4.55%
|
$22,750
$14.31 P/Share
|
Mar 07
2023
|
Craig Alan Curtis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+5.42%
|
$22,750
$14.31 P/Share
|
Mar 07
2023
|
Dana D. Behar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+5.29%
|
$22,750
$14.31 P/Share
|
Mar 07
2023
|
Lynn Terwoerds Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,849
+37.55%
|
$67,886
$14.91 P/Share
|
Mar 06
2023
|
Matthew Deines President / CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+2.41%
|
$26,000
$13.95 P/Share
|
Feb 01
2023
|
Terry A Anderson EVP, Chief Credit Officer |
SELL
Open market or private sale
|
Direct |
8,200
-27.11%
|
$123,000
$15.06 P/Share
|
Jan 07
2023
|
Matthew Deines President / CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
883
-1.11%
|
$13,245
$15.3 P/Share
|